# Exonics Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/exonics-therapeutics

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.exonicstx.com
- Total disclosed funding: $45M
- Latest round: Series A (Nov 8, 2017)
- Investors on record: 2

## About

Founded in 2017 and based in Massachusetts, US, Exonics Therapeutics, Inc. operates as a biotechnology company that focuses on developing SingleCut CRISPR, a gene repair technology for the treatment of neuromuscular diseases.

## Funding rounds

- Series A, Nov 8, 2017, $40M — The Column Group
- Seed, Feb 27, 2017, $5M — CureDuchenne Ventures

## Investors

- CureDuchenne Ventures (https://capitalatlas.ai/funds/cureduchenne-ventures) — Seed
- The Column Group (https://capitalatlas.ai/funds/the-column-group) — Series A